These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17593519)

  • 21. Gestational hyperlipidemic pancreatitis caused by type III hyperlipoproteinemia with apolipoprotein E2/E2 homozygote.
    Chuang TY; Chao CL; Lin BJ; Lu SC
    Pancreas; 2009 Aug; 38(6):716-7. PubMed ID: 19629007
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town.
    Pasquariello A; Pasquariello G; Innocenti M; Minnei F; Funel N; Lorusso P; Barsotti G
    J Nephrol; 2011; 24(3):381-5. PubMed ID: 21534236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.
    Lohse P; Rader DJ; Brewer HB
    J Biol Chem; 1992 Jul; 267(19):13642-6. PubMed ID: 1352296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia.
    Kempen HJ; Gevers Leuven JA; van der Voort HA; de Knijff P; Havekes L
    Metabolism; 1991 Mar; 40(3):231-5. PubMed ID: 2000034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127----Asp, Arg158----Cys) variant.
    Feussner G; Ziegler R
    Clin Investig; 1992 Jul; 70(7):614-7. PubMed ID: 1392432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
    J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal lipid metabolism and renal disorders.
    Saito T
    Tohoku J Exp Med; 1997 Mar; 181(3):321-37. PubMed ID: 9163848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka.
    Hirashima H; Komiya T; Toriu N; Hara S; Matsunaga A; Saito T; Muso E
    Clin Nephrol Case Stud; 2018; 6():45-51. PubMed ID: 30542638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature.
    Saito T; Sato H; Oikawa S; Kudo K; Kurihara I; Nakayama K; Abe K; Yoshinaga K; Sakaguchi H
    Am J Nephrol; 1993; 13(1):64-8. PubMed ID: 8322843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus.
    Suzaki K; Kobori S; Ueno S; Uehara M; Kayashima T; Takeda H; Fukuda S; Takahashi K; Nakamura N; Uzawa H
    Atherosclerosis; 1990 Jan; 80(3):181-9. PubMed ID: 2310424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia.
    Miller DB; Hegele RA; Wolfe BM; Huff MW
    J Clin Endocrinol Metab; 1995 Mar; 80(3):807-13. PubMed ID: 7883834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype.
    Feussner G; Ziegler R
    J Intern Med; 1991 Aug; 230(2):183-6. PubMed ID: 1865171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report.
    Cautero N; Di Benedetto F; De Ruvo N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; De Blasiis MG; Rompianesi G; Iemmolo RM; Marino M; Bertolotti M; Zivieri S; Gerunda GE
    Transplant Proc; 2010 May; 42(4):1349-51. PubMed ID: 20534298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathognomonic Palmar Crease Xanthomas of Apolipoprotein E2 Homozygosity-Familial Dysbetalipoproteinemia.
    Rothschild M; Duhon G; Riaz R; Jetty V; Goldenberg N; Glueck CJ; Wang P
    JAMA Dermatol; 2016 Nov; 152(11):1275-1276. PubMed ID: 27603268
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
    Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
    Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy.
    Hayakawa M; Okubo M; Katori H; Nagahama K; Murase T; Kobayashi T; Tanaka S; Nakanishi K; Odawara M; Matsushita H; Yamada A
    Am J Kidney Dis; 2002 Mar; 39(3):E15. PubMed ID: 11877595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes.
    Kato T; Ushiogi Y; Yokoyama H; Hara S; Matsunaga A; Muso E; Saito T
    CEN Case Rep; 2019 May; 8(2):106-111. PubMed ID: 30701487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.